These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 30087232)
21. Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties. Zhou Z; Guo J; Hetrick B; Tiwari S; Haikerwal A; Han Y; Bond VC; Huang MB; Mankowski MK; Snyder BA; Hogan PA; Sharma SK; Liotta DC; Reid TE; Wilson LJ; Wu Y PLoS Pathog; 2024 Aug; 20(8):e1012448. PubMed ID: 39146384 [TBL] [Abstract][Full Text] [Related]
22. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs. Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532 [TBL] [Abstract][Full Text] [Related]
23. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines. Juffermans NP; Paxton WA; Dekkers PE; Verbon A; de Jonge E; Speelman P; van Deventer SJ; van der Poll T Blood; 2000 Oct; 96(8):2649-54. PubMed ID: 11023494 [TBL] [Abstract][Full Text] [Related]
24. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829 [TBL] [Abstract][Full Text] [Related]
25. CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. Park IW; Koziel H; Hatch W; Li X; Du B; Groopman JE Am J Respir Cell Mol Biol; 1999 May; 20(5):864-71. PubMed ID: 10226056 [TBL] [Abstract][Full Text] [Related]
26. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. Simmons G; Wilkinson D; Reeves JD; Dittmar MT; Beddows S; Weber J; Carnegie G; Desselberger U; Gray PW; Weiss RA; Clapham PR J Virol; 1996 Dec; 70(12):8355-60. PubMed ID: 8970955 [TBL] [Abstract][Full Text] [Related]
27. Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV. Wilkins J; Zheng YM; Yu J; Liang C; Liu SL PLoS One; 2016; 11(6):e0156739. PubMed ID: 27257969 [TBL] [Abstract][Full Text] [Related]
28. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses. Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502 [TBL] [Abstract][Full Text] [Related]
29. Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1. Marziali F; Delpeuch M; Kumar A; Appourchaux R; Dufloo J; Tartour K; Etienne L; Cimarelli A J Virol; 2021 Aug; 95(18):e0043921. PubMed ID: 34160255 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992 [TBL] [Abstract][Full Text] [Related]
32. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411 [TBL] [Abstract][Full Text] [Related]
33. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123 [TBL] [Abstract][Full Text] [Related]
34. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes. Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060 [TBL] [Abstract][Full Text] [Related]
36. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1. Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575 [TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. Popik W; Alce TM; Au WC J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288 [TBL] [Abstract][Full Text] [Related]
38. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659 [TBL] [Abstract][Full Text] [Related]
39. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Wrensch F; Winkler M; Pöhlmann S Viruses; 2014 Sep; 6(9):3683-98. PubMed ID: 25256397 [TBL] [Abstract][Full Text] [Related]
40. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Yu J; Li M; Wilkins J; Ding S; Swartz TH; Esposito AM; Zheng YM; Freed EO; Liang C; Chen BK; Liu SL Cell Rep; 2015 Oct; 13(1):145-156. PubMed ID: 26387945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]